Skip to content

Clinical trials

Phase 4 Diabetes Mellitus trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 4 Country / region: China Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20031
20042
20052
20072
20083
20092
20103
20116
20122
20133
20141
20155
20163
20182
20214
20222
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Unknown status14
Not yet recruiting2
Recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S20
Eli Lilly and Company3
Nanjing First Hospital, Nanjing Medical University2
Peking Union Medical College Hospital2
Peking University Third Hospital2
Sun Yat-sen University2
Beijing Tsinghua Chang Gung Hospital1
China National Center for Cardiovascular Diseases1
China-Japan Friendship Hospital1
Chongqing Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus52
Diabetes Mellitus, Type 229
Metabolic Diseases3
Renal Insufficiency, Chronic3
Cardiovascular Diseases2
Chronic Limb-Threatening Ischemia2
Diabetes Mellitus, Type 12
Dry Eye Syndromes2
Hypertension2
Insulin Resistance2

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.